Alle Insider-Transaktionen auf den wichtigsten Aktienmärkten
| 30 Tage | Letzte 90 Tage | 120 Tage | |
|---|---|---|---|
| Durchschnittliche Rendite | -2% | 8.2% | 15.1% |
| Erfolgsquote | 51% | 68% | 82% |
| Transaktionen |
16
100% Kauf
|
34
71% Kauf
|
47
69% Kauf
|
| Position | Unternehmen | Zeitraum |
|---|---|---|
| Director | Kaleido Biosciences Inc | None - |
| President and Chief Executive Officer, Director | Spyre Therapeutics Inc | 10. Oktober 2019 - |
| President, Chief Executive Officer, Director | Spyre Therapeutics Inc | 1. Juli 2018 - 10. Oktober 2019 |
| Interim Chief Executive Officer, Director | Spyre Therapeutics Inc | 18. Juli 2017 - 1. Juli 2018 |
| Director, Interim Chief Medical Officer | Spyre Therapeutics Inc | 1. April 2017 - 1. Juli 2017 |
| Independent Director | Spyre Therapeutics Inc | 1. März 2016 - 1. April 2017 |